Research innovations from CPC investigators
Members of the Cancer Prevention and Control research program at IU Simon Comprehensive Cancer Center are leading remarkable laboratory and clinical studies that reduce the burden of cancer.
Guiding drug therapy using patient genetics
CPC members Tyler Shugg, PhD, Zeruesenay Desta, PhD, Bryan Schneider, MD, and Todd Skaar, PhD, are making an impact along with other colleagues from Indiana University School of Medicine.
Their study using patient genetics to guide drug therapy and manage drug interactions that could potentially benefit patients with advanced cancer was recently published in the renowned journal JCO Precision Oncology.
